Blockade of adenosine A2A receptors reverses early spatial memory defects in the APP/PS1 mouse model of Alzheimer’s disease by promoting synaptic plasticity of adult-born granule cells. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.